Kurzporträt
Mitarbeiterzahl: 6
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Dean Petkanas
CEO | Chief Executive Officer | 60 | 25.07.18 |
Mark Corrao
DFI | Director of Finance/CFO | 67 | 25.07.18 |
William Kinney
CTO | Chief Tech/Sci/R&D Officer | 66 | 25.07.18 |
Robert Malasek
BRD | Director/Board Member | 55 | 20.06.17 |
Mark McDonnell
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Robert Malasek
BRD | Director/Board Member | 55 | 20.06.17 |
Timothy Scott
BRD | Director/Board Member | 71 | 25.07.18 |
Dean Petkanas
CEO | Chief Executive Officer | 60 | 25.07.18 |
Blake Schroeder
BRD | Director/Board Member | 48 | 25.07.18 |
Thomas Kikis
FOU | Founder | 46 | 25.07.18 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 93 810 559 | 71 724 607 ( 76,46 %) | 0 | 76,46 % |
Unternehmenskontakt
Neuropathix, Inc.
Pennsylvania Biotechnology Center 3805 Old Easton Road
18902, Doylestown
+
http://www.neuropathix.comSektor
% 1. Jan. | Kap. | |
---|---|---|
-2.19% | 102 Mrd. | |
+2.33% | 96.09 Mrd. | |
+2.13% | 22.28 Mrd. | |
-17.00% | 21.4 Mrd. | |
-8.79% | 18.14 Mrd. | |
-39.98% | 17.02 Mrd. | |
-13.86% | 16.09 Mrd. | |
+5.19% | 13.83 Mrd. | |
+33.30% | 11.97 Mrd. |